Oppenheimer Initiates Coverage of Lemaitre Vascular (LMAT) with Outperform Recommendation
Fintel reports that on September 6, 2023, Oppenheimer initiated coverage of Lemaitre Vascular (NASDAQ:LMAT) with a Outperform recommendation.
Analyst Price Forecast Suggests 24.53% Upside
As of August 31, 2023, the average one-year price target for Lemaitre Vascular is 68.85. The forecasts range from a low of 58.58 to a high of $82.95. The average price target represents an increase of 24.53% from its latest reported closing price of 55.29.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Lemaitre Vascular is 175MM, a decrease of 1.38%. The projected annual non-GAAP EPS is 1.21.
Lemaitre Vascular Declares $0.14 Dividend
On July 25, 2023 the company declared a regular quarterly dividend of $0.14 per share ($0.56 annualized). Shareholders of record as of August 17, 2023 received the payment on August 31, 2023. Previously, the company paid $0.14 per share.